487163
Chloroform solution
suitable for NMR (reference standard), 1% in acetone-d6 (99.9 atom % D)
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
grade
analytical standard
Quality Level
concentration
1% in acetone-d6 (99.9 atom % D)
technique(s)
NMR: suitable
NMR tube size
5 mm × 7 in. , 5 mm × 8 in.
suitability
suitable for NMR (reference standard)
application(s)
environmental
format
single component solution
SMILES string
ClC(Cl)Cl
InChI
1S/CHCl3/c2-1(3)4/h1H
InChI key
HEDRZPFGACZZDS-UHFFFAOYSA-N
Features and Benefits
1H line shape
Preparation Note
5 mm O.D. tube contains 0.700 mL.
Still not finding the right product?
Explore all of our products under Chloroform solution
signalword
Danger
hcodes
Hazard Classifications
Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - STOT RE 2 Oral - STOT SE 3
target_organs
Central nervous system, Liver,Kidney
supp_hazards
Storage Class
3 - Flammable liquids
wgk
WGK 2
flash_point_f
1.4 °F - closed cup
flash_point_c
-17 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves
Regulatory Information
易制毒化学品（2类）
危险化学品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Matteo Serino et al.
PloS one, 6(6), e21184-e21184 (2011-06-24)
Daily variations in lipid concentrations in both gut lumen and blood are detected by specific sensors located in the gastrointestinal tract and in specialized central areas. Deregulation of the lipid sensors could be partly involved in the dysfunction of glucose
Ilaria Massarelli et al.
European journal of medicinal chemistry, 44(9), 3658-3664 (2009-03-11)
A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Carcinogenic Potency Database with the aim of developing QSAR models enabling prediction of the above unwanted property for New Chemical Entities. The dataset was rationally split into
Dennis J Pelletier et al.
Journal of chemical information and modeling, 47(3), 1196-1205 (2007-04-13)
The identification of phospholipidosis (PPL) during preclinical testing in animals is a recognized problem in the pharmaceutical industry. Depending on the intended indication and dosing regimen, PPL can delay or stop development of a compound in the drug discovery process.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 487163-8IN | 04061833646397 |
| 487163-7IN | 04061833646380 |